Cargando…
Ascorbic Acid Ameliorates Cardiac and Hepatic Toxicity Induced by Azithromycin-Etoricoxib Drug Interaction
The complexity of prescribing safe and effective drug therapy is still challenging. Due to the increased number of medications taken by patients, the potential for drug-drug interactions has clinically important consequences. This study focuses on the potential drug-drug interaction between azithrom...
Autores principales: | Hamza, Reham Z., Alaryani, Fatima S., Omara, Fatma, Said, Mahmoud A. A., El-Aziz, Sayed A. Abd, El-Sheikh, Sawsan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222074/ https://www.ncbi.nlm.nih.gov/pubmed/35735613 http://dx.doi.org/10.3390/cimb44060172 |
Ejemplares similares
-
Ascorbic-acid, azithromycin and hydroxychloroquine: Various toxicities: 3 case reports
Publicado: (2021) -
A case report on toxic epidermal necrolysis with etoricoxib
por: Kameshwari, J. S., et al.
Publicado: (2015) -
Synthesis, Spectroscopic Studies for Five New Mg (II), Fe (III), Cu (II), Zn (II) and Se (IV) Ceftriaxone Antibiotic Drug Complexes and Their Possible Hepatoprotective and Antioxidant Capacities
por: El-Megharbel, Samy M., et al.
Publicado: (2022) -
Validated HPLC–PDA methodology utilized for simultaneous determination of Etoricoxib and Paracetamol in the presence of Paracetamol toxic impurities
por: Abdel Rahman, Mona A., et al.
Publicado: (2022) -
The cardiovascular risks of etoricoxib (Arcoxia)
por: Sasich, Larry D., et al.
Publicado: (2008)